Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Cyclerion Therapeutics (CYCN)

Annual Return

Over the past 3 years, CYCN has had an average annual return of +1.09%, underperforming the benchmark SPY, which returned +19.31% annual.

Over the past 5 years, CYCN has had an average annual return of -45.29%, underperforming the benchmark SPY, which returned +12.78% annual.

Since Apr 2, 2019, CYCN has had an average annual return of -45.12%, underperforming the benchmark SPY, which returned +15.64% annual.

20262025202420232022202120202019
+184.09%-60.36%-4.31%-74.39%-61.84%-43.80%+12.52%-81.23%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+6.82%-0%+12.77%+115.09%-4.39%+7.34%+6.84%+184.09%
2025+21.62%-31.85%-6.52%+38.37%-18.49%+3.09%-9.00%-6.59%-7.06%-17.72%-15.38%-20.00%-60.36%
2024-10.34%+0%+5.77%-10.91%-6.12%-14.13%+56.96%-18.55%-11.88%+12.36%-24.00%+46.05%-4.31%
2023+2.21%-3.02%-33.41%-36.45%-21.05%-5.33%-22.54%+12.73%-4.84%-23.73%-16.67%+54.67%-74.39%
2022-23.25%-20.42%+5.66%-33.68%-15.35%-11.86%+74.93%-12.52%+2.41%-36.03%+72.63%-30.95%-61.84%
2021+3.27%+21.50%-27.36%-21.87%+48.67%+20.39%-25.41%+17.53%-10.21%-16.61%-14.88%-21.08%-43.80%
2020+20.62%+30.48%-38.08%+46.04%+2.85%+48.49%-35.38%+78.57%-10.86%-61.51%+31.64%-0.66%+12.52%
2019+5.11%-8.41%-17.92%-18.87%+2.37%+27.44%-80.28%-22.56%+46.99%-81.23%

Drawdown analysis of Cyclerion Therapeutics (CYCN)

The maximum drawdown for the CYCN was -99.71%, occurring on Feb 5, 2026. This drawdown has not yet recovered.

The current CYCN drawdown is -99.02%.

Since Apr 2, 2019 CYCN has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-99.71%Apr 10, 20191715Feb 5, 2026OngoingOngoingOngoing
-9.47%Apr 3, 20192Apr 5, 20193Apr 10, 20195